Serina Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Serina Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Serina Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.1M.
  • Serina Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.23M, a 1517% increase year-over-year.
  • Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $648K, a 14.7% decline from 2022.
  • Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $760K, a 24.2% decline from 2021.
  • Serina Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1M, a 7.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $648K -$112K -14.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $760K -$243K -24.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $1M +$70K +7.5% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-29
2020 $933K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2018 $184K -$227K -55.2% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
2017 $411K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.